Immunofluorescent light micrograph of a clump of cultured human breast cancer cells. Fluorescent dyes have been used to highlight proteins in the cell nuclei (purple), the Golgi apparatus (yellow) and extensive protrusions of actin (green). (Image: Dr Torsten Wittmann/SPL)
IT IS usually impossible to tell whether someone’s cancer will respond to therapy. That could change with the discovery of a genetic signature that predicts whether a variety of cancers will respond to the most common treatments. This could help identify which patients need drugs and radiotherapy, and which can be treated less aggressively.
at the University…
